Loading company…
S-Alpha Therapeutics develops digital therapeutics and health applications for people with chronic diseases.
Founded in 2019 and based in Seoul, South Korea, S-Alpha Therapeutics develops digital therapeutics and health apps for conditions including diabetes and mental illnesses. Its pipelines include SAT-001, SAT-002, SAT-006, SAT-008, and SAT-003 for ophthalmology, neurology, oncology, gastroenterology, and public crisis applications. It raised USD 2.7 million in seed funding in November 2020.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in